Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Amgen offers $762m to end Aranesp lawsuits

Pleads guilty to illegal marketing of anaemia drug

- PMLiVE

ViiV submits dolutegravir for approval to treat HIV in US, EU and Canada

GSK-Pfizer joint venture takes next step towards commercialisation

- PMLiVE

Biotest makes two senior management appointments

Promotion for Jörg Schüttrumpf while Markus Rothenburger joins from Fresenius Kabi

- PMLiVE

Guidance for local formularies in England could improve uptake

NICE publishes recommendations to address variations

- PMLiVE

Indigenus agencies honoured at 2012 Globals, CLIOs and Rx Club Awards

Global network of independent healthcare agencies features in all three awards

- PMLiVE

Year-end FDA approvals for Novartis, GSK drugs

Agency gives go-ahead to Cushing’s disease treatment Signifor and raxibacumab for inhalational anthrax

- PMLiVE

Teva expands presence in South Korea with Handok deal

Will supply products for distribution in market worth $14bn

- PMLiVE

GSK’s four-strain flu vaccine debuts in the US

Fluarix Quadrivalent protects against two influenza A and two influenza B subtypes

Pharma’s 2012 … going mobile

This year patients, prescribers and the public increasingly turned to their mobile devices

- PMLiVE

Almac appoints Charlie Morris as VP new products and services in clinical technologies division

Joins from Princeton Financial Systems

- PMLiVE

Early FDA approval for Ariad’s leukaemia drug Iclusig

Available in US three months ahead of schedule

- PMLiVE

Healing the ageing health issue

'Prime Timers' offer a wealth of opportunities to pharma as they hold back the sands of time

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links